argyrotsipi/train-dataset huggingface dataset:
NHS Capacity — House of Commons, 2022-03-01
Topic: Health
Sajid Javid (Conservative, Centre-right): We have worked with the NHS to expand virtual wards and establish a new national discharge taskforce to safely maximise patient discharge and free up beds. We have also announced a delivery plan for tackling the covid-19 backlog of elective care, which sets out our clear vision for how an additional £8 billion will be spent over the next three years to help the NHS to recover and expand elective services.
NHS Capacity — House of Commons, 2022-03-01
Topic: Health
David Anthony Evennett (Conservative, Centre-right): I thank my right hon. Friend for that information. As we look beyond the pandemic, our priority must be tackling the NHS waiting list. Does my right hon. Friend agree that the record number of doctors and nurses working in our NHS shows that the Government are putting the NHS on the best possible footing to meet the challenges ahead?
NHS Capacity — House of Commons, 2022-03-01
Topic: Health
Sajid Javid (Conservative, Centre-right): I absolutely agree with my right hon. Friend. Let me take this opportunity once again to thank everyone who has been working in the NHS, especially for all that they have done during the pandemic. We are continuing to invest in the workforce through our 50,000-person expansion in the nurse programme, and we already have 44,000 more full-time employees in healthcare settings than we had this time last year, including 4,600 more doctors and 11,100 more nurses.
NHS Capacity — House of Commons, 2022-03-01
Topic: Health
Sajid Javid (Conservative, Centre-right): The hon. Lady is right to raise this matter. As she will know, owing to the pressures of the pandemic we have seen significant challenges for ambulance services throughout the country. Just a few days ago I met the head of the West Midlands ambulance service to discuss some of the issues, and also how the extra funding that we provided over the winter—some £55 million of support for ambulance services—is helping.
Combat Air Strategy — House of Commons, 2018-07-17
Topic: Defense
Nia Rhiannon Griffith (Labour, Centre-left): I thank the Secretary of State for his statement and for advance sight of it. May I pay tribute to the former Defence Procurement Minister, the hon. Member for Aberconwy (Guto Bebb), who was forced to resign last night for supporting the Prime Minister’s position on Brexit Our aerospace and defence sectors are truly world leading and are vital to our security and national prosperity. We welcome the publication of the combat air strategy, but might it not have been better to publish an overarching defence industrial strategy to give the wider industry the certainty it requires? If the Secretary of State’s Department will not do that, will it publish a land strategy sometime in the near future A key aspect of the combat air strategy is the creation of a project to consider how to deliver next-generation capability. I am not quite sure how the Government adopted the name "Team Tempest", but it seems apt this week. The Secretary of State has been clear that the future approach hinges on international collaboration, so what discussion has he had with allies about this project? Has he considered the impact that partnering with non-NATO nations could have on our interoperability This strategy has been published at a time of great uncertainty in the aerospace industry about the impact of Brexit. Does the Secretary of State agree with the assessment of the industry, the trade body ADS and Members from across the House that the UK must be in a customs union to guarantee the industry’s future success The Secretary of State said that he wants to see the Tempest fly alongside the Typhoons and the F-35s. Will he confirm how many F-35s the Government plan to buy, in what timeframe and which variant they will be Rumours abound that the UK’s future airborne warning and control system capability will be gifted to a company without competition, just as the mechanised infantry vehicle was. Does the Secretary of State agree that that would be a hypocritical approach, when his defence industrial policy refresh emphasised the importance of competition? Can he confirm that there will be an open competition for the UK’s future AWACS capability? Members from across the House, our industrial partners and our allies are all eagerly awaiting the publication of the modernising defence programme. We were told that we would get the headlines before last week’s NATO summit, and then we were told that it would be out before the summer recess. In the light of the Government’s proposed new parliamentary timetable, will it be tomorrow or Thursday?
Combat Air Strategy — House of Commons, 2018-07-17
Topic: Defense
Ruth Smeeth (Labour, Centre-left): On 17 November 2017, we had a debate in the House about the need for a defence aerospace industrial strategy. This combat air strategy is one step forward, but it does not talk about sovereign skills in terms of the need for a training platform. May we have a serious conversation about what is going to happen at Brough?
Combat Air Strategy — House of Commons, 2018-07-17
Topic: Defense
Graham Peter Jones (Labour, Centre-left): I welcome the combat air strategy, but does the Secretary of State agree with my constituent Andrew Moxham, who wrote to me yesterday to ask how on earth the UK alone can afford this project? This can only be delivered as part of a collaboration—preferably a European collaboration, as with the Typhoon—and it will also require export orders. Britain alone cannot afford this project.
Combat Air Strategy — House of Commons, 2018-07-17
Topic: Defense
Madeleine Moon (Labour, Centre-left): I welcome the statement and the combat air strategy, but I say to the Secretary of State that it is deeply worrying how often we have gone to America to buy our fighters. Will we be looking to British industry to provide the AWACS aircraft, because these advance warning aircraft should be British-made and British-built?
Combat Air Strategy — House of Commons, 2018-07-17
Topic: Defense
Luke Pollard (Labour, Centre-left): France and Germany are already co-operating on a sixth-generation fighter, so although this strategy is welcome, we are playing catch-up. Will the Secretary of State set out whether this will be an allied, NATO, European or transatlantic project, and how will workshare benefit aerospace businesses, including those in Plymouth?
Combat Air Strategy — House of Commons, 2018-07-17
Topic: Defense
Wesley Paul William Streeting (Labour, Centre-left): The UK’s defence aerospace industry is vital for the future of our economy, providing higher-quality, high-skilled jobs up and down the country. What does it say about this Government’s ability to protect those jobs and that industry when one of the Secretary of State’s own Ministers resigns over the Government’s shambolic handling of Brexit negotiations? What are the implications of that shambolic handling not just for his Department and the industries it is supposed to champion, but for every other sector of our economy?
Combat Air Strategy — House of Commons, 2018-07-17
Topic: Defense
James Dolan Cunningham (Labour, Centre-left): I have worked in the defence industry. In fact, I worked at Rolls-Royce and a lot of people there probably welcome this statement. So that we can all welcome the statement, will the Secretary of State tell us who will fund it, how it will be funded and who are these new partners he is thinking about outside of Europe? If he is thinking about the United States, I am sure that many people in the defence industry will tell him that we always come off second best when we are up against them.
Points of Order — House of Commons, 2018-07-17
Topic: Health
Grahame Mark Morris (Labour, Centre-left): On a point of order, Mr Speaker. I received a reply from the Minister for Disabled People, Health and Work, the hon. Member for Truro and Falmouth (Sarah Newton), to parliamentary question 156404, which confirmed that an automatic insulin pump could be considered an aid in relation to the awarding of points for personal independence payments. However, when I raised the Minister’s answer with Atos, the independent assessment service, Barrie McKillop, the Atos clinical director, stated that its stance is correct. He said: "as it stands, I feel that you have been given an incorrect response by DWP" Mr Speaker, there appears to be a discrepancy between what the Minister is saying and the response from the organisation responsible for implementing the policy. The question of who is correct could have serious implications for a constituent of mine, who I believe is being unfairly denied access to PIP. Who actually has the final say on what the policy is in practice?
Covid-19 Lateral Flow Tests — House of Commons, 2022-03-01
Topic: Health
Margaret Ann Throup (Conservative, Centre-right): In advance of the living with covid announcement on 21 February, ministerial colleagues discussed our living with covid strategy with the devolved Administrations. Officials were also in regular touch to understand the approach being taken by each Administration and any implementation issues.
Covid-19 Lateral Flow Tests — House of Commons, 2022-03-01
Topic: Health
Margaret Ann Throup (Conservative, Centre-right): As the Prime Minister announced last week, free tests will continue until April. He also stated that if the SNP in Scotland wished to continue to offer free tests after that date, it is certainly at liberty to do so. I am proud that, because of the amazing success of the vaccination programme, covid rates are coming down, hospitalisations are coming down and deaths are coming down. It is because of that that we can now live with covid and reduce the ongoing expense of testing and bring it to a proportionate and manageable scenario.
Covid-19: Pharmaceutical Interventions — House of Commons, 2022-03-01
Topic: Health
Margaret Ann Throup (Conservative, Centre-right): Vaccines remain our best line of defence against covid-19. NHS staff and volunteers in our world-leading vaccination programme continue to work tirelessly, and I am sure the House thanks all of them. The offer of first, second and booster doses is always open. It is never too late to get jabbed We were the first country in the world to begin rolling out oral antivirals in the community, as part of a range of NHS antiviral and therapeutic treatment options to give us another line of defence. We are working hard to identify further safe and effective treatments through Government-funded national trials.
Covid-19: Pharmaceutical Interventions — House of Commons, 2022-03-01
Topic: Health
Miriam Joy Cates (Conservative, Centre-right): It was announced last month that covid vaccinations will be offered to healthy five to 11-year-olds, and the Joint Committee on Vaccination and Immunisation calculates that 2 million children in this age group will need to be vaccinated to prevent one intensive care unit admission, so any serious side effects occurring at a rate of more than one in 2 million would constitute a net harm. Given that reports of serious side effects, such as myocarditis, from other countries significantly exceed that rate, and given the lack of long-term safety data for the new vaccine, how confident are the Government that the vaccination of healthy five to 11-year-olds will do more good than harm?
Covid-19: Pharmaceutical Interventions — House of Commons, 2022-03-01
Topic: Health
Margaret Ann Throup (Conservative, Centre-right): We carefully considered and accepted the advice of the JCVI that the health benefits to five to 11-year-olds of a single dose of the covid-19 vaccine are greater than the potential health risks. I reassure the House that this is a non-urgent offer, and our priority is to continue vaccinating the most vulnerable.
NHS Managers: Performance and Efficiency — House of Commons, 2022-03-01
Topic: Health
Edward John Comport Argar (Conservative, Centre-right): The NHS is recognised as one of the most efficient health services in the world. Between 2010 and 2018, productivity in the NHS grew faster than in the wider economy. However, there is always room to do more. My right hon. Friend the Secretary of State has commissioned a review led by Dame Linda Pollard and General Sir Gordon Messenger to explore health and social care leadership and management, including the drivers of performance and efficiency, and they will report back later this year.
NHS Managers: Performance and Efficiency — House of Commons, 2022-03-01
Topic: Health
Edward John Comport Argar (Conservative, Centre-right): Possibly at some risk to my political prospects, I find myself in agreement with the hon. Gentleman on the importance of good and effective leadership. Of course I join him in his remarks about Ukraine I highlight that 84% of our NHS workforce are either clinically trained or are directly providing clinical support to clinicians, but it is also important that we recognise the importance and value of the administrators and managers who support the team. That is why we need the best people in those roles, and it is why my right hon. Friend the Secretary of State has commissioned the review led by two extremely eminent people. We are determined to continue driving up the quality and standards of management in the NHS.
Locum Doctors and Nurses — House of Commons, 2022-03-01
Topic: Health
Questions: If he will make an estimate of the percentage of (a) doctors and (b) nurses being paid locum rates in the latest week for which figures are available.
Edward John Comport Argar (Conservative, Centre-right): In NHS hospital trusts to date in 2021-22, there have been on average 14,826 full-time-equivalent agency nurses and 4,621 medical and dental FTE agency staff. It is hard to draw direct percentage comparisons given different methodologies for measuring such percentages, but my understanding is that overall about 3% of nursing shifts and about 1.5% of doctors’ shifts in hospitals are filled by locums or agency staff.
Locum Doctors and Nurses — House of Commons, 2022-03-01
Topic: Health
Questions: If he will make an estimate of the percentage of (a) doctors and (b) nurses being paid locum rates in the latest week for which figures are available.
Esther Louise McVey (Conservative, Centre-right): Can we get greater clarity on that information and have it held centrally, given that wages are such a large proportion of the NHS budget? It is essential to know how many hours are paid at the higher locum rate to ensure value for money for the extra billions of pounds that the Government are putting into the NHS to get waiting lists down and for social care.
Locum Doctors and Nurses — House of Commons, 2022-03-01
Topic: Health
Questions: If he will make an estimate of the percentage of (a) doctors and (b) nurses being paid locum rates in the latest week for which figures are available.
Edward John Comport Argar (Conservative, Centre-right): I am grateful to my right hon. Friend, who is tireless in her determination to ensure value for money for her and all of our taxpayers’ pounds, particularly in this space. We continue to work hard to drive down agency and locum spend, focusing instead on both bank staff and our full-time recruitment, on which the Secretary of State has set out the success that we have been having. Since 2015, we have controlled agency spend through price caps and procurement frameworks. However, she is absolutely right, and we want to see more full-time NHS employed staff working at NHS rates in our trusts.
Health Outcomes: Public-Private Partnerships — House of Commons, 2022-03-01
Topic: Health
Edward John Comport Argar (Conservative, Centre-right): Throughout the pandemic, partnerships between the public and private sectors have been vital in securing the resources to protect public health. As one element of that partnership, independent sector providers, for example, delivered almost 7 million episodes of care for NHS patients between April 2020 and December 2021 according to hospital episode statistics data. We continue to support the partnership approach more broadly as part of our plans both to tackle the backlog of elective care and to improve broader health outcomes.
Health Outcomes: Public-Private Partnerships — House of Commons, 2022-03-01
Topic: Health
Edward John Comport Argar (Conservative, Centre-right): The hon. Gentleman makes a typically sensible and reasonable point. Government advice on a healthy balanced diet is encapsulated in the UK’s national food model, the "Eatwell Guide". It includes advice on incorporating fibre into the diet through fruit and vegetables, bread, rice and pasta. We set nutritional standards for catering in all Government Departments and related organisations to improve the nutritional content of food served, including increasing fibre. I agree that it would be helpful to increase intakes of fibre in our diet, guided appropriately by clinical and medical advice, and a key element of achieving that is working with industry.
Motor Neurone Disease Research — House of Commons, 2022-03-01
Topic: Health
Questions: What his timescale is for awarding the £50 million funding for targeted motor neurone disease research through specific scientific programmes proposed by MND charities.
Gillian Keegan (Conservative, Centre-right): Researchers can apply right now to the National Institute for Health Research and UK Research and Innovation to access the £50 million of funding. The timescale for spending the money depends on the research applications received. The £50 million over five years is a minimum commitment, and we hope to spend much more than that on research in this vital area. We are working with the motor neurone community to help it effectively access the committed funding and to boost MND research even further.
Motor Neurone Disease Research — House of Commons, 2022-03-01
Topic: Health
Questions: What his timescale is for awarding the £50 million funding for targeted motor neurone disease research through specific scientific programmes proposed by MND charities.
Steven John Baker (Conservative, Centre-right): The Minister has made a positive announcement in the course of the last few months, and this is an important repetition, but there seems to be a slight miscommunication going on because organisations are telling me that they are not sure where the co-ordination is coming from. May I invite her to meet me and the coalition of patients and researchers to try to nail down exactly what is happening, in a spirit of good faith?
Children with Epilepsy: Treatments — House of Commons, 2022-03-01
Topic: Health
Questions: If his Department will make an assessment of the long-term impacts of use of (a) benzodiazepines and (b) other opioids on children being treated for acute forms of epilepsy.
Gillian Keegan (Conservative, Centre-right): Benzodiazepines are an important medicine in the treatment of severe cases of certain types of epileptic conditions in children. The Medicines and Healthcare products Regulatory Agency continues to monitor the safety of treatment with benzodiazepines. Opioids are not authorised to treat children for acute forms of epilepsy.
Children with Epilepsy: Treatments — House of Commons, 2022-03-01
Topic: Health
Questions: If his Department will make an assessment of the long-term impacts of use of (a) benzodiazepines and (b) other opioids on children being treated for acute forms of epilepsy.
Gillian Keegan (Conservative, Centre-right): The National Institute for Health Research welcomes funding applications for research into any aspect of human health, including epilepsy, and we would welcome those pharmaceutical companies coming forward to partake in trials. The NIHR and the NHS will support a programme of two randomised control trials into epilepsy, which will compare medicines containing cannabidiol, and CBD plus tetrahydrocannabinol and a placebo. This is a pioneering area of research, and I am aware that NHS England and NIHR are working closely to get those trials started as soon as possible.
Regional Health Inequalities — House of Commons, 2022-03-01
Topic: Health
Maria Colette Caulfield (Conservative, Centre-right): While I recognise that the waiting times in Hull are some of the highest in the country, I am sure the hon. Gentleman will welcome the investment that the Government are putting into his constituency to change that. The Royal Infirmary and Castle Hill Hospitals have £60 million of funding, and his own hospital recognises that it will provide some of the most modern facilities in the country. That includes £2.8 million for new respiratory wards, £1.6 million for new specialist theatre facilities, and £1.1 million for oxygen resilience wards, ensuring that his local hospital is able to tackle some of those health disparities.
Regional Health Inequalities — House of Commons, 2022-03-01
Topic: Health
Nicholas Anthony Fletcher (Conservative, Centre-right): In addition to regional disparities, will the Minister look into disparities between men and women’s health? Men die four years earlier than women on average, 75% of suicides are by men, and during the time taken for oral questions, one man will die from prostate cancer. Through my work as chair of the all-party group on issues affecting men and boys, we have taken evidence that points to the need for a men’s health strategy. The Government have done much over the years to reduce the gender pay gap. Will the Minister help me to reduce the gender age gap?
Regional Health Inequalities — House of Commons, 2022-03-01
Topic: Health
Maria Colette Caulfield (Conservative, Centre-right): I absolutely take the point that my hon. Friend makes around the disparity in life expectancy between those in the most and the least deprived areas, which is greater for men. We will be publishing the health disparities White Paper, and we will focus on any disparities, including those that affect men.
Regional Health Inequalities — House of Commons, 2022-03-01
Topic: Health
Maria Colette Caulfield (Conservative, Centre-right): I do not know whether the hon. Gentleman realises that there has been a pandemic for two years. The Government have committed funding for elective recovery. We are investing in those areas that are in greatest need in the country, including Hull. I am sure that the residents of Hull welcome the investment that the Government are making in their hospital.
Access to Orkambi — House of Commons, 2018-07-17
Topic: Health
Charalambos Charalambous (Labour, Centre-left): Orkambi would not be suitable for my constituent Holly, who is eight years old, but other drugs that have been manufactured would be more suitable for her. Does my hon. Friend agree that if NICE had more flexibility in looking at pipeline deals, that would help many more people such as my constituent Holly?
Access to Orkambi — House of Commons, 2018-07-17
Topic: Health
James Richard Frith (Labour, Centre-left): I congratulate my hon. Friend on securing this debate. Does he agree that there is a human cost to this gridlock for cystic fibrosis sufferers, who are victims of this disease and this disagreement? Frankly, NHS England should get in a room with Vertex and they should stay in there until they come out with an agreement to end this gridlock, so that cystic fibrosis sufferers do not see this debate just as yet another conversation but as delivering change and transformation of their lives.
Access to Orkambi — House of Commons, 2018-07-17
Topic: Health
Ian Austin (Labour, Centre-left): I am very grateful. This is a really frustrating process, and the Government have to find a way of bringing it to a conclusion. I agree that NHS England and Vertex have to get back into negotiations, which should not stop until this is resolved. Does my hon. Friend agree that it might be an idea for the Secretary of State to get Sir Simon Stevens and Jeff Leiden, the chief executive of Vertex, in a room—